The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy
Irena Dujmović(University of Belgrade), Jelena Drulović(University of Belgrade), Cinzia Quattrocchi, Nebojša Stojsavljević, Katia Mangano(University of Catania), Šarlota Mesaroš(University of Belgrade), Tatjana Pekmezović(University of Belgrade), Ferdinando Nicoletti(University of Catania)
Cited by 85
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495